These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 26842877)
21. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239 [TBL] [Abstract][Full Text] [Related]
22. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma. Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593 [TBL] [Abstract][Full Text] [Related]
23. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells. Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142 [TBL] [Abstract][Full Text] [Related]
24. High hydrostatic pressure induces immunogenic cell death in human tumor cells. Fucikova J; Moserova I; Truxova I; Hermanova I; Vancurova I; Partlova S; Fialova A; Sojka L; Cartron PF; Houska M; Rob L; Bartunkova J; Spisek R Int J Cancer; 2014 Sep; 135(5):1165-77. PubMed ID: 24500981 [TBL] [Abstract][Full Text] [Related]
25. Calreticulin-Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients. Kielbik M; Szulc-Kielbik I; Klink M Cells; 2021 Jan; 10(1):. PubMed ID: 33440842 [TBL] [Abstract][Full Text] [Related]
27. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups. Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362 [TBL] [Abstract][Full Text] [Related]
28. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Fucikova J; Truxova I; Hensler M; Becht E; Kasikova L; Moserova I; Vosahlikova S; Klouckova J; Church SE; Cremer I; Kepp O; Kroemer G; Galluzzi L; Salek C; Spisek R Blood; 2016 Dec; 128(26):3113-3124. PubMed ID: 27802968 [TBL] [Abstract][Full Text] [Related]
29. [Up-regulation of TIM-3 on CD4+ tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer]. Ji P; Chen D; Bian J; Xia R; Song X; Wen W; Zhang X; Zhu Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):808-11. PubMed ID: 26062425 [TBL] [Abstract][Full Text] [Related]
30. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination. Kim SG; Park MY; Kim CH; Sohn HJ; Kim HS; Park JS; Kim HJ; Oh ST; Kim TG Vaccine; 2008 Nov; 26(50):6433-40. PubMed ID: 18812201 [TBL] [Abstract][Full Text] [Related]
31. Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer. Donnem T; Al-Shibli K; Andersen S; Al-Saad S; Busund LT; Bremnes RM Cancer; 2010 Sep; 116(18):4318-25. PubMed ID: 20549821 [TBL] [Abstract][Full Text] [Related]
32. PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitors. Meniawy TM; Lake RA; McDonnell AM; Millward MJ; Nowak AK Lung Cancer; 2016 Mar; 93():9-16. PubMed ID: 26898608 [TBL] [Abstract][Full Text] [Related]
33. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal. Garg AD; Elsen S; Krysko DV; Vandenabeele P; de Witte P; Agostinis P Oncotarget; 2015 Sep; 6(29):26841-60. PubMed ID: 26314964 [TBL] [Abstract][Full Text] [Related]
34. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer. Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202 [TBL] [Abstract][Full Text] [Related]
35. Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. Kasikova L; Hensler M; Truxova I; Skapa P; Laco J; Belicova L; Praznovec I; Vosahlikova S; Halaska MJ; Brtnicky T; Rob L; Presl J; Kostun J; Cremer I; Ryska A; Kroemer G; Galluzzi L; Spisek R; Fucikova J J Immunother Cancer; 2019 Nov; 7(1):312. PubMed ID: 31747968 [TBL] [Abstract][Full Text] [Related]
36. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224 [TBL] [Abstract][Full Text] [Related]
37. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Martins I; Kepp O; Schlemmer F; Adjemian S; Tailler M; Shen S; Michaud M; Menger L; Gdoura A; Tajeddine N; Tesniere A; Zitvogel L; Kroemer G Oncogene; 2011 Mar; 30(10):1147-58. PubMed ID: 21151176 [TBL] [Abstract][Full Text] [Related]
38. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients. Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493 [TBL] [Abstract][Full Text] [Related]
39. The prognostic role of progesterone receptor expression in non-small cell lung cancer patients: Gender-related impacts and correlation with disease-specific survival. Skjefstad K; Richardsen E; Donnem T; Andersen S; Kiselev Y; Grindstad T; Hald SM; Al-Shibli K; Bremnes RM; Busund LT; Al-Saad S Steroids; 2015 Jun; 98():29-36. PubMed ID: 25668612 [TBL] [Abstract][Full Text] [Related]
40. Immune activation status of CD8+ T cells infiltrating non-small cell lung cancer. Trojan A; Urosevic M; Dummer R; Giger R; Weder W; Stahel RA Lung Cancer; 2004 May; 44(2):143-7. PubMed ID: 15084378 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]